Advances in predictive scoring system for intravenous immunoglobulin non-responsive Kawasaki disease / 国际儿科学杂志
International Journal of Pediatrics
; (6): 77-80, 2023.
Article
en Zh
| WPRIM
| ID: wpr-989040
Biblioteca responsable:
WPRO
ABSTRACT
Intravenous immunoglobulin(IVIG)is internationally recognized as the main treatment for Kawasaki disease(KD)in the acute phase, and its application can effectively reduce the incidence of coronary artery disease(CAL).However, in clinical practice, up to 26.8% of KD children do not respond to IVIG treatment, and their risk of CAL is higher and the degree of CAL is more severe.Early adjustment of treatment, such as early combined use of glucocorticoids, may play an important role in improving the prognosis and shortening the course of IVIG non-responsive KD.Therefore, early identification of IVIG non-response KD is of great significance to clinicians.In the past 20 years, domestic and foreign scholars have successively established predictive scoring system to predict the possibility of IVIG non-response in children with KD and optimize the early treatment.This article reviews the domestic and foreign research on the score system for predicting IVIG non-response in KD, in order to provide reference for clinical diagnosis and treatment.
Texto completo:
1
Banco de datos:
WPRIM
Idioma:
Zh
Revista:
International Journal of Pediatrics
Año:
2023
Tipo del documento:
Article